Developer docs
API playgroundTry for free, no card

Search company profiles

EvidNet

Full company profile

uuid0000ui6

Namestring
EvidNet
Legal namestring
evidnet Inc.
Websiteurl
evidnet.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

EvidNet is a Seoul-headquartered healthcare data analytics company founded in 2017 that operates the FeederNet RWD/RWE platform, converting heterogeneous hospital electronic medical record (EMR) data into the international OHDSI/OMOP Common Data Model (CDM) format to enable multi-center clinical research without centralizing raw patient data. The platform connects 46-50+ Korean hospitals covering 57M+ standardized patient records and 300B+ data points, integrated with national claims databases (HIRA, NHIS), genomic, medical imaging, and patient-generated health data. The company's full product suite, marketed under the EVIX brand, includes EVIX-ONE (multi-center collaborative research), EVIX-MART (ETL and data integration), EVIX-INSIGHT/INSIGHT PRO (RWE disease statistics across the top 500 diseases in Korea), EVIX-FIND (clinical trial site/patient identification with 10-business-day turnaround), EVIX-RESEARCH (retrospective cohort studies), EVIX-PV/PMS (MFDS-compliant postmarketing surveillance), EVIX-EXPLO (no-code GUI statistical analysis), and the more recent subscription products EVIX-Dynamics and EVIX-Tracker (pharma prescription analytics). A consumer-facing app, MediPangPang, integrates personal health records across hospitals.

EvidNet's revenue is generated through a mix of subscription platform access, on-demand contract research studies (pilot and full studies), data extension/ETL services, and clinical site identification projects, with primary customers being pharmaceutical and biotech companies (retrospective studies, postmarketing surveillance, prescription analytics), hospital and academic medical center researchers (multi-center studies), and government health authorities (CDM standardization projects). The company holds ISO/IEC 27001:2013 certification (the first Korean medical data platform to do so) and has built an international profile through OHDSI community participation, including a COVID-19 study-a-thon and a Gates Foundation-funded COVID-19 data standardization project. The platform also supports federated learning for AI model training across distributed hospital data.

Cumulatively funded at approximately $26.1M USD (Series A of ~$11.5M, Shinhan Financial Group investment of ~$7.7M, and combined Hanmi/SK seed of ~$6.9M), EvidNet initiated IPO preparation in March 2023, appointed a new President (Jeon Seung, formerly 20 years at IQVIA) in November 2022 to drive commercialization, and continues expanding its hospital network, international data partnerships, and product surface.

Short descriptiontext

EvidNet is a South Korea-based healthcare data analytics company that operates the FeederNet RWD/RWE platform, standardizing hospital EMR data into OHDSI/OMOP Common Data Model format to serve pharmaceutical companies, biotech firms, hospitals, and government health authorities with multi-center research and real-world evidence services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
real-world evidence platform, clinical data analytics, healthcare data standardization, pharmacovigilance services, clinical research software
Industry2 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
SIC code1 code
  • Services-Health Services8000
Product category
Real-World Evidence Platform
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Platform Services
TypeSubscription Recurring
Description

Annual/monthly subscription tiers for EVIX platform tools (EVIX-ONE, EVIX-INSIGHT, EVIX-EXPLO, EVIX-DYNAMICS, EVIX-TRACKER). Web-based dashboard enabling multi-access. Revenue from pharma, biotech, and healthcare company subscriptions for ongoing data analytics access.

evidnet.com
2On-Demand Contract Research
TypeProfessional Services
Description

Per-study fees for EVIX-RESEARCH (retrospective cohort studies, comparative effectiveness/safety studies) and EVIX-PV/PMS (postmarketing surveillance). Pilot studies (1-3 months) and full studies (longer duration) with manuscript preparation support for scientific publications. Study lead time varies by complexity and hospital administrative procedures.

evidnet.com
3Data Extension and ETL Services
TypeUsage Based
Description

EVIX-MART on-demand ETL and data quality management services converting and expanding data from various sources including national claims data, national statistics, medical imaging, genomic data, and patient-generated health data.

evidnet.com
4Clinical Site Identification
TypeProfessional Services
Description

EVIX-FIND fast-track aggregated patient count query service enabling pharma companies to quickly identify eligible clinical trial sites and patient numbers based on eligibility criteria. Results provided within 10 business days.

evidnet.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details3 tiers
1Web-based subscription tiers (EVIX-DYNAMICS, EVIX-TRACKER)
ModelSubscriptionBilling cadenceAnnual
Notes

New subscription-type products launched April 2024 for prescription trend and pattern analytics. Web-based dashboard enabling multi-access with easy information combination and detailed data analysis. Exact pricing tiers not publicly disclosed.

evidnet.com
2EVIX-RESEARCH pilot study and full study classifications
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Pilot studies typically require 1-3 months for completion. Full study projects include manuscript preparation support for scientific publications. Study lead time varies by complexity and hospital administrative procedures. Classification depends on external use and publication needs.

evidnet.com
3EVIX-INSIGHT PRO in-depth RWE subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Planned second-half 2020 launch for deeper RWE insights with cohort-specific information. Provides richer information on specific cohorts of interest compared to base EVIX-INSIGHT.

evidnet.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 13 records shown
1EVIX-ONE™
Description

Multicenter collaborative research platform for remote study design and execution

evidnet.com
+12 more records
Core offering1 text field

EvidNet operates the FeederNet RWD/RWE platform that standardizes hospital EMR data into a Common Data Model (CDM) and delivers a suite of analytics products (EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, EVIX-EXPLO, EVIX-Dynamics, EVIX-Tracker) for multi-center clinical research, retrospective studies, clinical trial site identification, pharmacovigilance, and prescription trend analytics. The platform also includes the MediPangPang/EVIX-HEALTH consumer app for personal health record management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Clinical research that previously took months to years can now be conducted in hours using the FeederNet distributed analysis network
+3 more records
Product overview1 text field

EvidNet is a healthcare data analytics company operating the FeederNet® RWD/RWE platform, which is a comprehensive ecosystem of interconnected products serving clinical researchers, pharmaceutical/ healthcare companies, and patients. The core platform is built around data standardization via CDM (Common Data Model) and provides specialized modules: EVIX-ONE™ for multicenter collaborative research, EVIX-MART™ for data integration/ETL services, EVIX-INSIGHT™/EVIX-INSIGHT PRO™ for disease analytics and RWE insights, EVIX-FIND™ for clinical trial site identification, EVIX-RESEARCH™ for retrospective studies, EVIX-PV/PMS™ for pharmacovigilance, and EVIX-EXPLO™ for no-code statistical analysis. The portfolio also includes subscription analytics tools EVIX-Dynamics™ and EVIX-Tracker™ for pharmaceutical prescription analysis, plus consumer-facing MediPangPang/EVIX-HEALTH™ app for personal health record management.

Product and service11 records
1EVIX-ONE
CategoryClinical research software platform
Description

Multicenter collaborative research platform enabling remote study design and execution across partner hospitals' data networks for clinical researchers and pharmaceutical companies. Supports cohort definitions, comparative effectiveness studies, and AI modeling through integrated ATLAS interface.

2EVIX-MART
CategoryData integration and ETL service
Description

On-demand ETL and data quality management service converting, expanding, and integrating data from EMR systems, national claims data (HIRA/NHIS), medical imaging, genomic data, and patient-generated health data.

3EVIX-INSIGHT
CategoryReal-world evidence analytics
Description

Real-world evidence platform providing disease statistics on top 500 diseases in Korea, including frequently prescribed drugs, procedures, and lab tests based on HIRA and hospital EMR data.

4EVIX-INSIGHT PRO
CategoryReal-world evidence analytics
Description

Advanced RWE platform providing in-depth cohort-specific insights for specific research interests, offering richer information on specific cohorts compared to the base EVIX-INSIGHT.

5EVIX-FIND
CategoryClinical trial site identification service
Description

Fast-track aggregated patient count query service for clinical trial site selection, providing eligibility criteria matching and hospital contact points within 10 business days for pharmaceutical companies.

6EVIX-RESEARCH
CategoryContract retrospective research service
Description

On-demand retrospective research service supporting comparative effectiveness studies, safety studies, lab test analysis, adverse drug reaction prediction, and regulatory submission documentation for pharmaceutical companies.

7EVIX-PV/PMS
CategoryPharmacovigilance and postmarketing surveillance service
Description

Postmarketing surveillance service using RWD/RWE platform for drug adverse event detection and effectiveness/safety monitoring in compliance with MFDS database study guidelines.

8EVIX-EXPLO
CategoryNo-code statistical analysis tool
Description

GUI-based exploratory data analysis tool enabling no-code statistical analysis and visualization for researchers without coding expertise, supporting CDM format and various public datasets.

9EVIX-Dynamics
CategoryPrescription analytics software
Description

Subscription-based pharmaceutical prescription statistics analysis product providing prescription trend analytics, including hospital inpatient prescription statistics not available in external pharmacy data. Web dashboard-based with multi-access capability.

10EVIX-Tracker
CategoryPrescription analytics software
Description

Subscription-based pharmaceutical prescription statistics tracking tool providing prescription pattern analysis with web dashboard for multi-access and detailed data analysis capabilities.

11MediPangPang / EVIX-HEALTH (메디팡팡)
CategoryPersonal health record application
Description

Consumer-facing medical mydata platform app integrating and managing personal health records from multiple hospitals, supporting telemedicine services. Operated by the Medipangpang CIC subsidiary established in January 2022.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-07-02
Description

MOU signed in July 2024 for joint RMP (Risk Management Plan) business using RWD/RWE. Partnership combines EvidNet's RWD/RWE platform with Medisafe's drug safety management expertise to launch innovative services in 'database study-based post-market safety management'. Medisafe's CEO Im Min-jung leads drug safety operations with 20+ years of multinational pharma experience.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-02-19
Description

MOU signed in February 2024 with MTG, a medical imaging AI solutions company. Partnership aims to: (1) provide analysis services combining clinical data with medical imaging analysis data, and (2) pursue mutual cooperation for overseas business expansion. MTG's unstructured medical video data analysis technology combined with EvidNet's structured data creates synergies in healthcare diagnostics.

3Seoul National University Graduate School AI Major (서울대학교 대학원 협동과정 인공지능전공)
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-11-15
Description

MOU signed in November 2023 for AI research cooperation in the medical field. Partnership aims to strengthen research cooperation in medical AI technology development and big data. Joint efforts to advance medical AI technology through academic-industry collaboration.

evidnet.com
4DreamCiiA (드림씨아이에스)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-02-20
Description

MOU signed in February 2023 for joint clinical and RWE research business. Partnership to pursue collaborative research projects in clinical studies and real-world evidence using EvidNet's RWD/RWE platform capabilities.

evidnet.com
5National Health Insurance Service Ilsan Hospital (국민건강보험 일산병원)
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-10-13
Description

MOU signed in September-October 2022 for CDM data-based research cooperation enhancement. Partnership established clinical data infrastructure through CDM linkage between the hospital and EvidNet's data network, enabling collaborative research projects.

evidnet.com
6Korea Roche Diagnostics (한국로슈진단)
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-03-21
Description

Partnership through EvidNet serving as 'data partner' for Korea Roche Diagnostics' NebiFi TumorBoard platform at Kangwon National University Hospital. EvidNet handles technical integration between the hospital's EMR and Roche's clinical decision support platform. Demonstrates EvidNet's role as a data infrastructure provider for major global healthcare companies.

evidnet.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-06-29
Description

MOU for medical big data utilization signed in June 2021. Partnership to utilize the hospital's clinical data for multi-center collaborative research through EvidNet's standardized data platform.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-27
Description

Data-based research cooperation agreement signed in May 2021. Partnership enables the hospital to participate in multi-center research projects through EvidNet's data network and standardization technology.

9Daegu Catholic University Hospital (대구가톨릭대병원)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-04
Description

'Data Research Innovation Project' agreement signed in May 2021. Partnership to advance the hospital's data research capabilities through EvidNet's standardized data infrastructure and CDM conversion technology.

evidnet.com
10NewFlight (뉴플라이트)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-08-03
Description

MOU signed in August 2020 for AI-based drug repurposing research. Partnership aimed at accelerating drug discovery through AI analysis using EvidNet's clinical big data combined with NewFlight's bio company builder capabilities. Targeting early clinical entry and faster commercialization through drug repositioning.

evidnet.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-06-22
Description

MOU signed in June 2020 for immune-oncology drug development. Utilitex received NSCLC, CRC, HCC biomarkers and related data from EvidNet to support clinical planning for its immune-oncology pipeline using AI-powered analysis of real-world patient data.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-12-17
Description

CDM-based global clinical trial support service agreement signed in December 2019. Kangwon National University Hospital provides quality medical data through CDM linkage while EvidNet provides data analysis technology. Partnership aims to attract diverse global clinical trials and activate the international research ecosystem.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2019-08-30
Description

Strategic MOU signed in August 2019 for CDM-based Clinical Data Warehouse (CDW) development and service provision. Partnership leverages Miso's CDW technology (for integrating clinical and research data, EMR text and structured data) with EvidNet's CDM standardization. Pilot service targeted for January 2020.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-07-01
Description

MOU signed in June 2019 for cooperation in RWD/RWE (Real World Data/Evidence) fields. IQVIA is a global life sciences analytics and tech solutions company. The partnership aims to elevate EvidNet's CDM data quality to regulatory-grade standards and activate the CDM-based research ecosystem in Korea through joint academic events and research collaboration.

15Korea 41+ Hospitals (CDM Network)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-09-01
Description

Distributed bio-health big data project involving 41+ hospitals and 34,000+ hospital beds in a CDM-based data standardization initiative. Industry-Academia-Research collaboration for converting hospital medical information to Common Data Model (CDM) format. Project led by the Ministry of Trade, Industry and Energy and coordinated with companies including SK, ViewN, and StandardM.

evidnet.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

TriNetX operates a global federated health research network enabling clinical trial site identification and real-world evidence generation across hospital networks. Most direct peer to EvidNet's FeederNet platform, with comparable OMOP/CDM-based federated research model, though TriNetX has significantly broader global hospital coverage while EvidNet is Korea-focused.

TypeBroad incumbent
Description

Global leader in real-world evidence, clinical research, and life sciences analytics. Both a strategic partner of EvidNet (MOU since 2019) and the dominant global competitor in RWE/RWD platforms. EvidNet's new President Jeon Seung came from IQVIA, and the two collaborate in Korean RWE ecosystem development.

TypeDirect peer
Description

US-based oncology-focused real-world evidence company (acquired by Roche) that aggregates de-identified patient data from oncology clinics and partners with pharma for RWE generation. Direct peer in RWE platform business with similar pharma/biotech customer base, though focused on oncology rather than full therapeutic area coverage.

4Tempus Labs
TypeDirect peer
Description

AI-powered precision medicine company combining clinical and molecular data for RWE generation and pharma R&D support. Peer in the RWD/RWE space with similar technology approach of integrating multi-modal data (clinical, genomic, imaging) for pharma and clinical research use cases.

TypeDirect peer
Description

Real-world evidence analytics platform used by pharma, payers, and regulators for drug development, market access, and safety studies. Direct peer in RWE analytics for pharma R&D and regulatory submissions, with comparable focus on regulatory-grade evidence for FDA/HSA submissions.

TypeBroad incumbent
Description

Healthcare data and analytics platform serving health systems and life sciences companies with data warehousing, analytics, and population health insights. Comparable in healthcare data analytics but broader scope, with primary focus on health system customers rather than pharma R&D.

TypeBroad incumbent
Description

Health data connectivity platform that enables de-identified data exchange across healthcare organizations for research and analytics. Comparable in healthcare data infrastructure with similar privacy-preserving data linkage capabilities, though focused on data connectivity layer rather than analytics applications.

TypeBroad incumbent
Description

Clinical trial technology platform providing EDC, CTMS, eCOA, and analytics for life sciences R&D. Comparable in clinical trial informatics and pharma R&D technology stack, though Medidata focuses on trial execution while EvidNet focuses on real-world evidence generation from clinical practice data.

TypeRegional player
Description

Japanese healthcare technology and data company providing physician panels, clinical research, and RWE services across Asia. Regional peer in Asia-Pacific healthcare data with similar business model of aggregating healthcare professional and patient data for pharma R&D use cases.

TypeBroad incumbent
Description

Healthcare technology company providing EHR systems, practice management, and data analytics to hospitals and ambulatory providers. Comparable in healthcare data infrastructure with access to large-scale clinical data, with analytics offerings that overlap EvidNet's hospital data analytics capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EvidNet

Real-World Evidence Platformevidnet.com

EvidNet is a South Korea-based healthcare data analytics company that operates the FeederNet RWD/RWE platform, standardizing hospital EMR data into OHDSI/OMOP Common Data Model format to serve pharmaceutical companies, biotech firms, hospitals, and government health authorities with multi-center research and real-world evidence services.

What EvidNet does

EvidNet is a Seoul-headquartered healthcare data analytics company founded in 2017 that operates the FeederNet RWD/RWE platform, converting heterogeneous hospital electronic medical record (EMR) data into the international OHDSI/OMOP Common Data Model (CDM) format to enable multi-center clinical research without centralizing raw patient data. The platform connects 46-50+ Korean hospitals covering 57M+ standardized patient records and 300B+ data points, integrated with national claims databases (HIRA, NHIS), genomic, medical imaging, and patient-generated health data. The company's full product suite, marketed under the EVIX brand, includes EVIX-ONE (multi-center collaborative research), EVIX-MART (ETL and data integration), EVIX-INSIGHT/INSIGHT PRO (RWE disease statistics across the top 500 diseases in Korea), EVIX-FIND (clinical trial site/patient identification with 10-business-day turnaround), EVIX-RESEARCH (retrospective cohort studies), EVIX-PV/PMS (MFDS-compliant postmarketing surveillance), EVIX-EXPLO (no-code GUI statistical analysis), and the more recent subscription products EVIX-Dynamics and EVIX-Tracker (pharma prescription analytics). A consumer-facing app, MediPangPang, integrates personal health records across hospitals.

EvidNet's revenue is generated through a mix of subscription platform access, on-demand contract research studies (pilot and full studies), data extension/ETL services, and clinical site identification projects, with primary customers being pharmaceutical and biotech companies (retrospective studies, postmarketing surveillance, prescription analytics), hospital and academic medical center researchers (multi-center studies), and government health authorities (CDM standardization projects). The company holds ISO/IEC 27001:2013 certification (the first Korean medical data platform to do so) and has built an international profile through OHDSI community participation, including a COVID-19 study-a-thon and a Gates Foundation-funded COVID-19 data standardization project. The platform also supports federated learning for AI model training across distributed hospital data.

Cumulatively funded at approximately $26.1M USD (Series A of ~$11.5M, Shinhan Financial Group investment of ~$7.7M, and combined Hanmi/SK seed of ~$6.9M), EvidNet initiated IPO preparation in March 2023, appointed a new President (Jeon Seung, formerly 20 years at IQVIA) in November 2022 to drive commercialization, and continues expanding its hospital network, international data partnerships, and product surface.

EvidNet firmographics

Firmographics
Name
EvidNet
Legal name
evidnet Inc.
Website
https://evidnet.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
EvidNet is a South Korea-based healthcare data analytics company that operates the FeederNet RWD/RWE platform, standardizing hospital EMR data into OHDSI/OMOP Common Data Model format to serve pharmaceutical companies, biotech firms, hospitals, and government health authorities with multi-center research and real-world evidence services.
Ownership category
akta.pro rank

EvidNet industry classification

Industry
Product category
Real-World Evidence Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

Keywords

  • Real-world evidence platform
  • Clinical data analytics
  • Healthcare data standardization
  • Pharmacovigilance services
  • Clinical research software

Where EvidNet is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

EvidNet business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Subscription Platform Services: Annual/monthly subscription tiers for EVIX platform tools (EVIX-ONE, EVIX-INSIGHT, EVIX-EXPLO, EVIX-DYNAMICS, EVIX-TRACKER). Web-based dashboard enabling multi-access. Revenue from pharma, biotech, and healthcare company subscriptions for ongoing data analytics access.
  2. On-Demand Contract Research: Per-study fees for EVIX-RESEARCH (retrospective cohort studies, comparative effectiveness/safety studies) and EVIX-PV/PMS (postmarketing surveillance). Pilot studies (1-3 months) and full studies (longer duration) with manuscript preparation support for scientific publications. Study lead time varies by complexity and hospital administrative procedures.
  3. Data Extension and ETL Services: EVIX-MART on-demand ETL and data quality management services converting and expanding data from various sources including national claims data, national statistics, medical imaging, genomic data, and patient-generated health data.
  4. Clinical Site Identification: EVIX-FIND fast-track aggregated patient count query service enabling pharma companies to quickly identify eligible clinical trial sites and patient numbers based on eligibility criteria. Results provided within 10 business days.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualWeb-based subscription tiers (EVIX-DYNAMICS, EVIX-TRACKER)
SubscriptionMulti-year contractEVIX-RESEARCH pilot study and full study classifications
SubscriptionAnnualEVIX-INSIGHT PRO in-depth RWE subscription

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

EvidNet product offering

Product offering

Core offering

EvidNet operates the FeederNet RWD/RWE platform that standardizes hospital EMR data into a Common Data Model (CDM) and delivers a suite of analytics products (EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, EVIX-EXPLO, EVIX-Dynamics, EVIX-Tracker) for multi-center clinical research, retrospective studies, clinical trial site identification, pharmacovigilance, and prescription trend analytics. The platform also includes the MediPangPang/EVIX-HEALTH consumer app for personal health record management.

Product overview

EvidNet is a healthcare data analytics company operating the FeederNet® RWD/RWE platform, which is a comprehensive ecosystem of interconnected products serving clinical researchers, pharmaceutical/ healthcare companies, and patients. The core platform is built around data standardization via CDM (Common Data Model) and provides specialized modules: EVIX-ONE™ for multicenter collaborative research, EVIX-MART™ for data integration/ETL services, EVIX-INSIGHT™/EVIX-INSIGHT PRO™ for disease analytics and RWE insights, EVIX-FIND™ for clinical trial site identification, EVIX-RESEARCH™ for retrospective studies, EVIX-PV/PMS™ for pharmacovigilance, and EVIX-EXPLO™ for no-code statistical analysis. The portfolio also includes subscription analytics tools EVIX-Dynamics™ and EVIX-Tracker™ for pharmaceutical prescription analysis, plus consumer-facing MediPangPang/EVIX-HEALTH™ app for personal health record management.

Differentiator

Problem solved

Functional benefit

Brands

  • EVIX-ONE™: Multicenter collaborative research platform for remote study design and execution
  • EVIX-MART™
  • EVIX-FIND™
  • EVIX-RESEARCH™
  • EVIX-PV/PMS™
  • EVIX-INSIGHT™
  • EVIX-INSIGHT PRO™
  • EVIX-EXPLO™
  • EVIX-Dynamics™
  • EVIX-Tracker™
  • 메디팡팡 (Medipangpang)
  • 피더넷 (FeederNet®)
  • Evix-Health™

Products and services

  • EVIX-ONE Multicenter collaborative research platform enabling remote study design and execution across partner hospitals' data networks for clinical researchers and pharmaceutical companies. Supports cohort definitions, comparative effectiveness studies, and AI modeling through integrated ATLAS interface.
  • EVIX-MART On-demand ETL and data quality management service converting, expanding, and integrating data from EMR systems, national claims data (HIRA/NHIS), medical imaging, genomic data, and patient-generated health data.
  • EVIX-INSIGHT Real-world evidence platform providing disease statistics on top 500 diseases in Korea, including frequently prescribed drugs, procedures, and lab tests based on HIRA and hospital EMR data.
  • EVIX-INSIGHT PRO Advanced RWE platform providing in-depth cohort-specific insights for specific research interests, offering richer information on specific cohorts compared to the base EVIX-INSIGHT.
  • EVIX-FIND Fast-track aggregated patient count query service for clinical trial site selection, providing eligibility criteria matching and hospital contact points within 10 business days for pharmaceutical companies.
  • EVIX-RESEARCH On-demand retrospective research service supporting comparative effectiveness studies, safety studies, lab test analysis, adverse drug reaction prediction, and regulatory submission documentation for pharmaceutical companies.
  • EVIX-PV/PMS Postmarketing surveillance service using RWD/RWE platform for drug adverse event detection and effectiveness/safety monitoring in compliance with MFDS database study guidelines.
  • EVIX-EXPLO GUI-based exploratory data analysis tool enabling no-code statistical analysis and visualization for researchers without coding expertise, supporting CDM format and various public datasets.
  • EVIX-Dynamics Subscription-based pharmaceutical prescription statistics analysis product providing prescription trend analytics, including hospital inpatient prescription statistics not available in external pharmacy data. Web dashboard-based with multi-access capability.
  • EVIX-Tracker Subscription-based pharmaceutical prescription statistics tracking tool providing prescription pattern analysis with web dashboard for multi-access and detailed data analysis capabilities.
  • MediPangPang / EVIX-HEALTH (메디팡팡) Consumer-facing medical mydata platform app integrating and managing personal health records from multiple hospitals, supporting telemedicine services. Operated by the Medipangpang CIC subsidiary established in January 2022.

Quantifiable outcome

  • Clinical research that previously took months to years can now be conducted in hours using the FeederNet distributed analysis network
  • +3 more outcomes

Companies that use EvidNet

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

EvidNet technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

EvidNet partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered strategic, minor, major and core.

  • Medisafe Korea (메디세이프)strategicStrategic or Co-development Partner · 2 July 2024MOU signed in July 2024 for joint RMP (Risk Management Plan) business using RWD/RWE. Partnership combines EvidNet's RWD/RWE platform with Medisafe's drug safety management expertise to launch innovative services in 'database study-based post-market safety management'. Medisafe's CEO Im Min-jung leads drug safety operations with 20+ years of multinational pharma experience.
  • MTG (엠티이지)strategicStrategic or Co-development Partner · 19 February 2024MOU signed in February 2024 with MTG, a medical imaging AI solutions company. Partnership aims to: (1) provide analysis services combining clinical data with medical imaging analysis data, and (2) pursue mutual cooperation for overseas business expansion. MTG's unstructured medical video data analysis technology combined with EvidNet's structured data creates synergies in healthcare diagnostics.
  • Seoul National University Graduate School AI Major (서울대학교 대학원 협동과정 인공지능전공)strategicStrategic or Co-development Partner · 15 November 2023MOU signed in November 2023 for AI research cooperation in the medical field. Partnership aims to strengthen research cooperation in medical AI technology development and big data. Joint efforts to advance medical AI technology through academic-industry collaboration.
  • DreamCiiA (드림씨아이에스)minorStrategic or Co-development Partner · 20 February 2023MOU signed in February 2023 for joint clinical and RWE research business. Partnership to pursue collaborative research projects in clinical studies and real-world evidence using EvidNet's RWD/RWE platform capabilities.
  • National Health Insurance Service Ilsan Hospital (국민건강보험 일산병원)strategicStrategic or Co-development Partner · 13 October 2022MOU signed in September-October 2022 for CDM data-based research cooperation enhancement. Partnership established clinical data infrastructure through CDM linkage between the hospital and EvidNet's data network, enabling collaborative research projects.
  • Korea Roche Diagnostics (한국로슈진단)strategicStrategic or Co-development Partner · 21 March 2022Partnership through EvidNet serving as 'data partner' for Korea Roche Diagnostics' NebiFi TumorBoard platform at Kangwon National University Hospital. EvidNet handles technical integration between the hospital's EMR and Roche's clinical decision support platform. Demonstrates EvidNet's role as a data infrastructure provider for major global healthcare companies.
  • Korea University Anam Hospital (고려대학교 안암병원)minorStrategic or Co-development Partner · 29 June 2021MOU for medical big data utilization signed in June 2021. Partnership to utilize the hospital's clinical data for multi-center collaborative research through EvidNet's standardized data platform.
  • Soonchunhyang University Seoul Hospital (순천향대서울병원)minorStrategic or Co-development Partner · 27 May 2021Data-based research cooperation agreement signed in May 2021. Partnership enables the hospital to participate in multi-center research projects through EvidNet's data network and standardization technology.
  • Daegu Catholic University Hospital (대구가톨릭대병원)minorStrategic or Co-development Partner · 4 May 2021'Data Research Innovation Project' agreement signed in May 2021. Partnership to advance the hospital's data research capabilities through EvidNet's standardized data infrastructure and CDM conversion technology.
  • NewFlight (뉴플라이트)minorStrategic or Co-development Partner · 3 August 2020MOU signed in August 2020 for AI-based drug repurposing research. Partnership aimed at accelerating drug discovery through AI analysis using EvidNet's clinical big data combined with NewFlight's bio company builder capabilities. Targeting early clinical entry and faster commercialization through drug repositioning.
  • Utilitex (유틸렉스)minorStrategic or Co-development Partner · 22 June 2020MOU signed in June 2020 for immune-oncology drug development. Utilitex received NSCLC, CRC, HCC biomarkers and related data from EvidNet to support clinical planning for its immune-oncology pipeline using AI-powered analysis of real-world patient data.
  • Kangwon National University Hospital (강원대학교병원)minorStrategic or Co-development Partner · 17 December 2019CDM-based global clinical trial support service agreement signed in December 2019. Kangwon National University Hospital provides quality medical data through CDM linkage while EvidNet provides data analysis technology. Partnership aims to attract diverse global clinical trials and activate the international research ecosystem.
  • Miso Information Technology (미소정보기술)strategicTechnology or Integration · 30 August 2019Strategic MOU signed in August 2019 for CDM-based Clinical Data Warehouse (CDW) development and service provision. Partnership leverages Miso's CDW technology (for integrating clinical and research data, EMR text and structured data) with EvidNet's CDM standardization. Pilot service targeted for January 2020.
  • IQVIA Korea (아이큐비아)majorStrategic or Co-development Partner · 1 July 2019MOU signed in June 2019 for cooperation in RWD/RWE (Real World Data/Evidence) fields. IQVIA is a global life sciences analytics and tech solutions company. The partnership aims to elevate EvidNet's CDM data quality to regulatory-grade standards and activate the CDM-based research ecosystem in Korea through joint academic events and research collaboration.
  • Korea 41+ Hospitals (CDM Network)coreStrategic or Co-development Partner · 1 September 2018Distributed bio-health big data project involving 41+ hospitals and 34,000+ hospital beds in a CDM-based data standardization initiative. Industry-Academia-Research collaboration for converting hospital medical information to Common Data Model (CDM) format. Project led by the Ministry of Trade, Industry and Energy and coordinated with companies including SK, ViewN, and StandardM.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

EvidNet competitors and assessment

Company assessment

Direct peers

  • TriNetX: TriNetX operates a global federated health research network enabling clinical trial site identification and real-world evidence generation across hospital networks. Most direct peer to EvidNet's FeederNet platform, with comparable OMOP/CDM-based federated research model, though TriNetX has significantly broader global hospital coverage while EvidNet is Korea-focused.
  • Flatiron Health: US-based oncology-focused real-world evidence company (acquired by Roche) that aggregates de-identified patient data from oncology clinics and partners with pharma for RWE generation. Direct peer in RWE platform business with similar pharma/biotech customer base, though focused on oncology rather than full therapeutic area coverage.
  • Tempus Labs: AI-powered precision medicine company combining clinical and molecular data for RWE generation and pharma R&D support. Peer in the RWD/RWE space with similar technology approach of integrating multi-modal data (clinical, genomic, imaging) for pharma and clinical research use cases.
  • Aetion: Real-world evidence analytics platform used by pharma, payers, and regulators for drug development, market access, and safety studies. Direct peer in RWE analytics for pharma R&D and regulatory submissions, with comparable focus on regulatory-grade evidence for FDA/HSA submissions.

Broad incumbents

  • IQVIA: Global leader in real-world evidence, clinical research, and life sciences analytics. Both a strategic partner of EvidNet (MOU since 2019) and the dominant global competitor in RWE/RWD platforms. EvidNet's new President Jeon Seung came from IQVIA, and the two collaborate in Korean RWE ecosystem development.
  • Health Catalyst: Healthcare data and analytics platform serving health systems and life sciences companies with data warehousing, analytics, and population health insights. Comparable in healthcare data analytics but broader scope, with primary focus on health system customers rather than pharma R&D.
  • Datavant: Health data connectivity platform that enables de-identified data exchange across healthcare organizations for research and analytics. Comparable in healthcare data infrastructure with similar privacy-preserving data linkage capabilities, though focused on data connectivity layer rather than analytics applications.
  • Medidata Solutions (Dassault Systèmes): Clinical trial technology platform providing EDC, CTMS, eCOA, and analytics for life sciences R&D. Comparable in clinical trial informatics and pharma R&D technology stack, though Medidata focuses on trial execution while EvidNet focuses on real-world evidence generation from clinical practice data.
  • Veradigm (formerly Allscripts): Healthcare technology company providing EHR systems, practice management, and data analytics to hospitals and ambulatory providers. Comparable in healthcare data infrastructure with access to large-scale clinical data, with analytics offerings that overlap EvidNet's hospital data analytics capabilities.

Regional players

  • M3 (M3 Inc.): Japanese healthcare technology and data company providing physician panels, clinical research, and RWE services across Asia. Regional peer in Asia-Pacific healthcare data with similar business model of aggregating healthcare professional and patient data for pharma R&D use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

EvidNet social profiles

Digital presence

EvidNet compliance and trust

Trust signal

Compliance1 record

EvidNet financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EvidNet leadership team

Management profile

Number of profiles

Profiles3 records

EvidNet subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

EvidNet funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EvidNet M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EvidNet

What does EvidNet do?

EvidNet operates the FeederNet RWD/RWE platform that standardizes hospital EMR data into a Common Data Model (CDM) and delivers a suite of analytics products (EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, EVIX-EXPLO, EVIX-Dynamics, EVIX-Tracker) for multi-center clinical research, retrospective studies, clinical trial site identification, pharmacovigilance, and prescription trend analytics. The platform also includes the MediPangPang/EVIX-HEALTH consumer app for personal health record management.

Is EvidNet a public or private company?

EvidNet is a private company. It is classified as venture growth investor backed and is currently operating.

When was EvidNet founded?

EvidNet was founded in 2017. It employs 11 to 50 people.

Where is EvidNet based?

EvidNet is headquartered in Seoul, South Korea, in the Asia region.

How does EvidNet make money?

Four revenue lines are on record. Subscription Platform Services are the primary driver. The others are on-Demand Contract Research, data Extension and ETL Services and clinical Site Identification.

Who are EvidNet's main competitors?

Direct peers on record are TriNetX, Flatiron Health, Tempus Labs and Aetion. Broad incumbents are IQVIA, Health Catalyst, Datavant, Medidata Solutions (Dassault Systèmes) and Veradigm (formerly Allscripts). M3 (M3 Inc.) is listed as a regional player.

Does EvidNet have an API?

No public API is recorded for EvidNet.

What industry is EvidNet in?

EvidNet's product category is Real-World Evidence Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 5182 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireData4Life and EvidNet form strategic partnership to advance federated real-world evidence generationData4Life and EvidNet announced a strategic partnership to develop a global federated real-world evidence (RWE) generation infrastructure, integrating EvidNet's network of over 50 hospitals in South Korea with Data4Life's Data2Evidence platform. The collaboration aims to facilitate privacy-preserving, high-quality health research across borders using standards like OMOP and FHIR, with a proof-of-concept project scheduled for Q4 2025.YahooData4Life and EvidNet form strategic partnership to advance federated real-world evidence generationData4Life and EvidNet announced a strategic partnership to co-develop a global infrastructure for federated real-world evidence generation. The collaboration integrates EvidNet's FeederNet network with Data4Life's Data2Evidence platform, aiming to provide privacy-preserving, interoperable research data. A joint proof-of-concept project is scheduled to launch in Q4 2025.PrwebClinerion and EvidNet partner to drive healthcare forward by extending their global reach and technologies for real-world data-driven solutions.Clinerion and EvidNet announced a partnership to extend their real-world data offerings to healthcare organizations. EvidNet's network covers 36 million patient records from 27 hospitals in Asia, while Clinerion's platform includes 73.4 million patients across 20 countries. The collaboration aims to accelerate patient access to medicines and improve health outcomes.PR NewswireTriNetX Expands into South Korea in Partnership with EvidNetTriNetX has expanded its global health research network into South Korea through a partnership with EvidNet, which will contribute healthcare data from 36 million patient records across 27 hospitals. This collaboration aims to provide pharmaceutical and CRO partners with immediate access to enriched Asian healthcare data, leveraging South Korea's strong infrastructure for randomized clinical trials.